Evidence map›Paper›PMID 32798517›Full record

ArticleUrology2021

Assessing Contemporary Trends in Female Speakership within Urologic Oncology.

Ruchika Talwar, Adrien Bernstein, Amanda Jones, Juanita Crook, Andrea B Apolo, Jennifer M Taylor, Lauren M Burke, Elizabeth R Plimack, Sima P Porten, Kirsten L Greene and 2 more

Abstract read
In one paragraph

Article in Urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ruchika TalwarDivision of Urology, University of Pennsylvania, Philadelphia, PA; Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA. Electronic address: ruchika.talwar@pennmedicine.upenn.edu.
Adrien BernsteinDivision of Urology, Fox Chase Cancer Center, Philadelphia, PA.
Amanda JonesDivision of Urology, University of Pennsylvania, Philadelphia, PA.
Juanita CrookBCCA Center for the Southern Interior, University of British Columbia, Kelowna, BC, Canada.
Andrea B ApoloCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Jennifer M TaylorDepartment of Urology, Baylor College of Medicine, Houston, TX.
Lauren M BurkeDepartment of Radiology, Division of Abdominal Imaging, University of North Carolina, Chapel Hill, NC.
Elizabeth R PlimackDepartment of Hematology-Oncology, Fox Chase Cancer Center, Philadelphia, PA.
Sima P PortenDepartment of Urology, University of California San Francisco, San Francisco, CA.
Kirsten L GreeneDepartment of Urology, University of VA, Charlottesville, VA.
Sarah P PsutkaDepartment of Urology, University of Washington, Seattle, WA.
Angela B SmithDepartment of Urology, University of North Carolina, Chapel Hill, NC.

Funding

Bladder Cancer ProgramZIABC011351 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI APOLO, ANDREA · 2010 to 2025
$9.4M
Intramural NIH HHS ZIA BC011351
6 · The paper itself

Abstract

objectiveTo evaluate multidisciplinary female representation at urologic oncology conferences, we reviewed speakership trends at contemporary Society of Urologic Oncology (SUO) and American Society of Clinical Oncology Genitourinary Symposium (GU-ASCO) annual meetings.

methodsMeeting programs from SUO and GU-ASCO from 2015 to 2019 were analyzed. Biographical information was determined by querying institutional websites and social/professional media platforms. Statistical analyses were performed to assess for differences and relationships between male and female authorship based on gender, specialty, professional, and educational factors.

resultsWe identified 1102 speakers at genitourinary oncology conferences. Overall, 222 (20%) were female. There was no significant difference between female speakership rates at SUO and GU-ASCO. The overall proportion of female speakers increased over time, but not when analyzing each individual subspecialty conference separately. Several professional and educational differences were noted between genders. Female speakers were more likely to be medical oncologists (P <.001), have more recent years of graduation (2001 vs 1996, P <.001), hold an additional advanced degree (OR 2.09, P = .005), and speak in sessions where other women served as chair (OR 1.42, P = .044). Conversely, female speakers had lower odds of delivering a plenary or keynote address (OR 0.28, P = .015).

conclusionWe identified a significantly positive trend towards increased female representation within contemporary genitourinary conferences over time; these trends did not remain significant when analyzing each meeting separately. Several important disparities between men and women speakers were identified. Our data suggests that inclusion of women in planning committees may help reduce gender bias and promote diversity within urologic oncology.

Indexed as

Medical OncologyUrologyCongresses as TopicFemaleHumansPhysicians, WomenSocieties, MedicalUnited States

Identifiers

PMID32798517
PMCPMC9257999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.